State of Wyoming’s Telix Pharmaceuticals TLX Stock Holding History

State of Wyoming’s Portfolio TLX Stock Details TLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,293	Closed	-$12.4K	–	2141
2025 Q3	$12.4K	Buy	+1,293	New	+$15.8K	﹤0.01%	1748

Other funds holding TLX

PIC

Portland Investment Counsel Burlington, Ontario, Canada $312M AUM 53.32% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return

State of Wyoming's TLX Position: Q4 2025 in Review

State of Wyoming sold out of Telix Pharmaceuticals (TLX) in Q4 2025, closing a stake of 1,293 shares — an estimated $12.4K sold.

State of Wyoming first reported a position in TLX in Q3 2025 and held it in 1 quarter. The position peaked at $12.4K in Q3 2025. 40 funds tracked by Wall St. Rank hold TLX as of Q4 2025.

State of Wyoming reported no remaining Telix Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
State of Wyoming sold 1,293 Telix Pharmaceuticals shares in Q4 2025, an estimated $12.4K.
State of Wyoming first reported a position in Telix Pharmaceuticals in Q3 2025 and held it in 1 quarter.
State of Wyoming's Telix Pharmaceuticals position peaked at $12.4K in Q3 2025.
40 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q4 2025.

Based on State of Wyoming's 13F filing for Q4 2025, filed 11 Feb 2026.